Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

PR Newswire associated2

Tags

Cambrex-Snapdragon

More Like This

PR Newswire associated0

Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology

PR Newswire associated0

Cambrex Announces Sale of Drug Product Business Unit

PR Newswire associated0

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

PR Newswire associated0

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule

PR Newswire associated0

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

PR Newswire associated0

Ajinomoto Bio-Pharma Services Garners Six 'CDMO Leadership Awards,' Further Establishing Its Industry Excellence

Advanced Manufacturing, Global Reach, and Streamlined Services — Asymchem Impresses at CPHI Milan 2024

Asymchem’s Fully Automated Peptide Production Lines Set New Benchmarks as Large-Scale Capacity Continues to Grow